Ganmaa Davaasambuu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 29 | 2023 | 3270 | 2.010 |
Why?
|
| Mongolia | 29 | 2023 | 93 | 1.790 |
Why?
|
| Vitamin D Deficiency | 13 | 2023 | 1348 | 1.640 |
Why?
|
| Milk | 14 | 2018 | 436 | 1.470 |
Why?
|
| Tuberculosis, Pulmonary | 5 | 2022 | 836 | 1.030 |
Why?
|
| Food, Fortified | 6 | 2020 | 189 | 1.010 |
Why?
|
| Latent Tuberculosis | 5 | 2023 | 223 | 0.990 |
Why?
|
| Dietary Supplements | 18 | 2023 | 3428 | 0.920 |
Why?
|
| Cholecalciferol | 7 | 2023 | 550 | 0.670 |
Why?
|
| Urban Population | 9 | 2019 | 2038 | 0.650 |
Why?
|
| Respiratory Tract Infections | 6 | 2021 | 1008 | 0.640 |
Why?
|
| Tuberculosis | 5 | 2022 | 2010 | 0.630 |
Why?
|
| Vitamins | 10 | 2023 | 1630 | 0.580 |
Why?
|
| Rickets | 1 | 2023 | 66 | 0.430 |
Why?
|
| Nutrition Surveys | 3 | 2019 | 1735 | 0.390 |
Why?
|
| Seasons | 6 | 2019 | 1521 | 0.380 |
Why?
|
| Progesterone | 3 | 2020 | 752 | 0.370 |
Why?
|
| Tuberculin Test | 4 | 2020 | 205 | 0.350 |
Why?
|
| Estrone | 2 | 2020 | 234 | 0.350 |
Why?
|
| Rural Population | 6 | 2019 | 2317 | 0.340 |
Why?
|
| Estrogens | 6 | 2016 | 1528 | 0.320 |
Why?
|
| Flour | 1 | 2018 | 22 | 0.310 |
Why?
|
| Contact Tracing | 2 | 2022 | 274 | 0.310 |
Why?
|
| Food Industry | 1 | 2019 | 68 | 0.300 |
Why?
|
| Oils | 1 | 2018 | 54 | 0.300 |
Why?
|
| Triticum | 1 | 2018 | 92 | 0.300 |
Why?
|
| Deficiency Diseases | 1 | 2018 | 74 | 0.300 |
Why?
|
| Prolactin | 1 | 2020 | 627 | 0.290 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 197 | 0.290 |
Why?
|
| Students, Public Health | 1 | 2017 | 6 | 0.290 |
Why?
|
| Pre-Eclampsia | 2 | 2022 | 1256 | 0.270 |
Why?
|
| Diet | 11 | 2020 | 8085 | 0.260 |
Why?
|
| Sunlight | 3 | 2017 | 336 | 0.250 |
Why?
|
| Rural Health | 1 | 2017 | 302 | 0.250 |
Why?
|
| Double-Blind Method | 11 | 2023 | 12423 | 0.250 |
Why?
|
| Antitubercular Agents | 2 | 2019 | 1380 | 0.250 |
Why?
|
| Dairy Products | 2 | 2011 | 490 | 0.240 |
Why?
|
| Growth | 1 | 2017 | 365 | 0.240 |
Why?
|
| Food Preferences | 1 | 2018 | 397 | 0.230 |
Why?
|
| Awareness | 1 | 2019 | 653 | 0.230 |
Why?
|
| Urban Health | 1 | 2017 | 532 | 0.230 |
Why?
|
| Models, Economic | 1 | 2018 | 719 | 0.220 |
Why?
|
| Attitude | 1 | 2019 | 767 | 0.220 |
Why?
|
| Estradiol | 2 | 2020 | 1947 | 0.220 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2019 | 828 | 0.210 |
Why?
|
| Pregnancy | 12 | 2023 | 30235 | 0.200 |
Why?
|
| Pneumonia | 1 | 2023 | 2159 | 0.190 |
Why?
|
| Fetal Blood | 1 | 2018 | 1366 | 0.190 |
Why?
|
| Reproduction | 2 | 2005 | 645 | 0.180 |
Why?
|
| Nutritional Status | 3 | 2021 | 1621 | 0.170 |
Why?
|
| Female | 46 | 2023 | 396354 | 0.160 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 21157 | 0.160 |
Why?
|
| Animal Husbandry | 1 | 2018 | 64 | 0.150 |
Why?
|
| Premenopause | 3 | 2016 | 1039 | 0.150 |
Why?
|
| Testicular Neoplasms | 3 | 2003 | 805 | 0.150 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 26294 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2018 | 2694 | 0.150 |
Why?
|
| Child | 18 | 2023 | 80668 | 0.140 |
Why?
|
| Dermatitis, Atopic | 1 | 2014 | 734 | 0.140 |
Why?
|
| Humans | 53 | 2023 | 766432 | 0.140 |
Why?
|
| Fractures, Bone | 2 | 2023 | 2043 | 0.130 |
Why?
|
| Population Dynamics | 1 | 2018 | 314 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2021 | 9352 | 0.130 |
Why?
|
| Tea | 1 | 2008 | 289 | 0.130 |
Why?
|
| Male | 34 | 2023 | 363975 | 0.130 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2019 | 587 | 0.130 |
Why?
|
| Prevalence | 8 | 2023 | 15820 | 0.130 |
Why?
|
| Diet Surveys | 1 | 2020 | 1159 | 0.130 |
Why?
|
| Odds Ratio | 4 | 2021 | 9654 | 0.130 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2007 | 292 | 0.130 |
Why?
|
| Fish Oils | 1 | 2019 | 483 | 0.120 |
Why?
|
| Uterus | 2 | 2006 | 660 | 0.120 |
Why?
|
| Growth Hormone | 1 | 2007 | 572 | 0.120 |
Why?
|
| Young Adult | 14 | 2020 | 59928 | 0.120 |
Why?
|
| Pregnancy, Animal | 1 | 2005 | 124 | 0.120 |
Why?
|
| Adult | 25 | 2020 | 223253 | 0.110 |
Why?
|
| Gerbillinae | 1 | 2023 | 87 | 0.110 |
Why?
|
| Students, Medical | 1 | 2017 | 1962 | 0.110 |
Why?
|
| Cattle | 5 | 2011 | 3814 | 0.110 |
Why?
|
| Coffee | 1 | 2008 | 593 | 0.110 |
Why?
|
| Caffeine | 1 | 2008 | 702 | 0.110 |
Why?
|
| Drinking | 1 | 2004 | 196 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2021 | 10379 | 0.110 |
Why?
|
| Adolescent | 13 | 2023 | 88898 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2019 | 10740 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2020 | 1910 | 0.100 |
Why?
|
| Endocrine Disruptors | 1 | 2005 | 264 | 0.100 |
Why?
|
| Reproductive History | 1 | 2013 | 210 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 1380 | 0.100 |
Why?
|
| Micronutrients | 2 | 2020 | 390 | 0.100 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2004 | 496 | 0.090 |
Why?
|
| Sputum | 2 | 2019 | 513 | 0.090 |
Why?
|
| Hormones | 1 | 2014 | 866 | 0.090 |
Why?
|
| Sperm Count | 1 | 2001 | 227 | 0.090 |
Why?
|
| Transients and Migrants | 1 | 2013 | 170 | 0.090 |
Why?
|
| Vomiting | 1 | 2023 | 652 | 0.090 |
Why?
|
| Testis | 1 | 2003 | 784 | 0.080 |
Why?
|
| Population | 1 | 2019 | 140 | 0.080 |
Why?
|
| Social Marketing | 1 | 2019 | 51 | 0.080 |
Why?
|
| Risk Factors | 10 | 2021 | 74828 | 0.080 |
Why?
|
| Rats, Wistar | 4 | 2006 | 1889 | 0.080 |
Why?
|
| Mycobacterium bovis | 1 | 2019 | 148 | 0.080 |
Why?
|
| Anthropometry | 1 | 2013 | 1336 | 0.080 |
Why?
|
| Dietary Fats | 3 | 2020 | 2001 | 0.080 |
Why?
|
| Demography | 1 | 2013 | 1641 | 0.080 |
Why?
|
| Infertility, Male | 1 | 2001 | 395 | 0.080 |
Why?
|
| Hematologic Tests | 1 | 2019 | 239 | 0.080 |
Why?
|
| Birth Weight | 1 | 2016 | 2123 | 0.080 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2019 | 238 | 0.070 |
Why?
|
| Life Style | 3 | 2016 | 3926 | 0.070 |
Why?
|
| Middle Aged | 16 | 2020 | 223127 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2021 | 12061 | 0.070 |
Why?
|
| Animals | 17 | 2023 | 168887 | 0.070 |
Why?
|
| Ovarian Neoplasms | 2 | 2005 | 4904 | 0.070 |
Why?
|
| Incidence | 8 | 2020 | 21509 | 0.070 |
Why?
|
| Energy Intake | 2 | 2020 | 2142 | 0.070 |
Why?
|
| Diarrhea | 1 | 2023 | 1317 | 0.070 |
Why?
|
| Boston | 2 | 2020 | 9333 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 1365 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2005 | 1424 | 0.070 |
Why?
|
| BCG Vaccine | 1 | 2019 | 381 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2008 | 3208 | 0.060 |
Why?
|
| Child Development | 1 | 2007 | 2327 | 0.060 |
Why?
|
| Testosterone | 1 | 2016 | 2495 | 0.060 |
Why?
|
| Genome, Human | 1 | 2018 | 4443 | 0.060 |
Why?
|
| Postpartum Period | 1 | 2022 | 1195 | 0.060 |
Why?
|
| Rats | 7 | 2006 | 23718 | 0.060 |
Why?
|
| Prostate | 1 | 2003 | 1757 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 1 | 2018 | 917 | 0.060 |
Why?
|
| Occupations | 1 | 2016 | 516 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 746 | 0.060 |
Why?
|
| Japan | 3 | 2003 | 1417 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2007 | 1935 | 0.060 |
Why?
|
| Smoking | 2 | 2021 | 9076 | 0.050 |
Why?
|
| Sex Factors | 2 | 2018 | 10614 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2019 | 24272 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2018 | 1001 | 0.050 |
Why?
|
| Placebos | 1 | 2017 | 1659 | 0.050 |
Why?
|
| Schools | 1 | 2021 | 1495 | 0.050 |
Why?
|
| China | 1 | 2019 | 2383 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1791 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2023 | 42576 | 0.050 |
Why?
|
| Pharmacy Service, Hospital | 1 | 1983 | 134 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2018 | 2351 | 0.050 |
Why?
|
| Cost Savings | 1 | 2017 | 902 | 0.050 |
Why?
|
| Prostatic Neoplasms | 3 | 2003 | 11094 | 0.050 |
Why?
|
| Parity | 2 | 2014 | 931 | 0.050 |
Why?
|
| Asthma | 1 | 2019 | 6267 | 0.040 |
Why?
|
| Disease Progression | 2 | 2019 | 13632 | 0.040 |
Why?
|
| Comorbidity | 3 | 2020 | 10579 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 578 | 0.040 |
Why?
|
| Body Weight | 3 | 2005 | 4625 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2022 | 54826 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20129 | 0.040 |
Why?
|
| Archaeology | 1 | 2018 | 38 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65202 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2003 | 896 | 0.040 |
Why?
|
| Diet Records | 1 | 2020 | 425 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2017 | 2503 | 0.040 |
Why?
|
| History, Ancient | 1 | 2018 | 213 | 0.040 |
Why?
|
| Ergocalciferols | 1 | 2019 | 105 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2019 | 13045 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6306 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2020 | 531 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 6327 | 0.030 |
Why?
|
| Health Promotion | 1 | 2019 | 2207 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2022 | 8532 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2019 | 361 | 0.030 |
Why?
|
| Peru | 1 | 2019 | 888 | 0.030 |
Why?
|
| Eating | 2 | 2004 | 1538 | 0.030 |
Why?
|
| Dietary Fiber | 1 | 2020 | 767 | 0.030 |
Why?
|
| Aged | 6 | 2021 | 171234 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2017 | 3138 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 416 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2016 | 570 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2019 | 702 | 0.030 |
Why?
|
| Cohort Effect | 1 | 2004 | 39 | 0.030 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2004 | 58 | 0.030 |
Why?
|
| Fruit | 1 | 2020 | 1166 | 0.030 |
Why?
|
| Vegetables | 1 | 2020 | 1199 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2006 | 256 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 592 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 2913 | 0.030 |
Why?
|
| Food Supply | 1 | 2020 | 544 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 39283 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2016 | 957 | 0.030 |
Why?
|
| Dehydrocholesterols | 1 | 2013 | 20 | 0.030 |
Why?
|
| Food Contamination | 1 | 2005 | 193 | 0.030 |
Why?
|
| Genitalia | 1 | 2004 | 114 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 4055 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2653 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2006 | 612 | 0.030 |
Why?
|
| Genitalia, Female | 1 | 2004 | 146 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 81588 | 0.030 |
Why?
|
| Mass Screening | 1 | 2019 | 5451 | 0.030 |
Why?
|
| Folic Acid | 1 | 2020 | 1337 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 872 | 0.030 |
Why?
|
| Body Composition | 1 | 2023 | 2441 | 0.030 |
Why?
|
| Minority Groups | 1 | 2020 | 1208 | 0.030 |
Why?
|
| Lactation | 1 | 2005 | 392 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 2007 | 640 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 8061 | 0.030 |
Why?
|
| Cheese | 1 | 2002 | 39 | 0.020 |
Why?
|
| Anal Canal | 1 | 2004 | 375 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 7240 | 0.020 |
Why?
|
| Europe | 1 | 2018 | 3427 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2005 | 706 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2003 | 357 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 780 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 2108 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5302 | 0.020 |
Why?
|
| Ovary | 1 | 2005 | 963 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2011 | 41703 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4850 | 0.020 |
Why?
|
| Internationality | 1 | 2005 | 1006 | 0.020 |
Why?
|
| Fertility | 1 | 2004 | 770 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2004 | 703 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 1167 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 9601 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2510 | 0.020 |
Why?
|
| Age Factors | 2 | 2019 | 18395 | 0.020 |
Why?
|
| Postmenopause | 1 | 2008 | 2517 | 0.020 |
Why?
|
| Time Factors | 3 | 2011 | 40116 | 0.020 |
Why?
|
| Nurses | 1 | 2008 | 2503 | 0.020 |
Why?
|
| Food | 1 | 2003 | 764 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 16042 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 14071 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2005 | 4014 | 0.020 |
Why?
|
| Infant | 2 | 2019 | 36460 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7840 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2868 | 0.020 |
Why?
|
| Obesity | 2 | 2020 | 13088 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 15639 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2007 | 8720 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2004 | 2559 | 0.010 |
Why?
|
| Women's Health | 1 | 2013 | 2080 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 2970 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 59538 | 0.010 |
Why?
|
| Nursing | 1 | 1983 | 35 | 0.010 |
Why?
|
| Drug Storage | 1 | 1983 | 52 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8107 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14760 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 10092 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15897 | 0.010 |
Why?
|
| Neoplasms | 1 | 2021 | 22343 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2003 | 393 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 5872 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22245 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14643 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2016 | 4858 | 0.010 |
Why?
|
| Hospitalization | 1 | 2020 | 10812 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 1180 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10438 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 12236 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7426 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 26388 | 0.010 |
Why?
|
| Physicians | 1 | 2016 | 4591 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2003 | 1812 | 0.010 |
Why?
|
| Triglycerides | 1 | 2003 | 2441 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 2903 | 0.010 |
Why?
|
| United States | 1 | 2008 | 72910 | 0.010 |
Why?
|
| Insulin | 1 | 2003 | 6608 | 0.000 |
Why?
|